Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
13.99    0.47 (3.48%)
Bid:
13.89
Ask:
14.25
Spread: 0.36 (2.592%)
Market Cap: £203.96m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

Director Dealing

27 Mar 2025 10:00

RNS Number : 5031C
Pantheon Resources PLC
27 March 2025
 

27 March 2025

 

Pantheon Resources plc

Director Dealing

 

Pantheon Resources plc ("Pantheon" or "the Company"), the AIM-quoted oil and gas exploration company with 100% working interests in the Ahpun and Kodiak projects spanning 258,000 acres adjacent to transportation and pipeline infrastructure on the Alaska North Slope, announces the following on market director purchases:

1. Jeremy Brest, non-executive director, has purchased 1,084,929 shares on market at an average price of £0.6918 per share. Following the purchase his ultimate beneficial ownership increases to 3,849,679 shares, representing 0.33% of the Company's total voting rights.

2. Linda Havard, non-executive director, has purchased 21,000 shares on market at an average price of £0.704 per share. Following the purchase her ultimate beneficial ownership increases to 118,559 shares, representing 0.01% of the Company's total voting rights.

This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.  

Details of the transaction are reported in the PDMR Notification below:

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

a. Jeremy Brest

b. Linda Havard

2

Reason for the notification

 

a)

Position/status

a. Non-Executive Director

b. Non-Executive Director

 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pantheon Resources plc

 

b)

LEI

213800SWHY5DNQS64J23

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each fully paid

 

ISIN: GB00B125SX82

 

c)

Currency

GBP

d)

Price(s) and volumes(s)

Price(s)

Volume(s)

 

a. £0.6918

b. £0.704

a. 1,084,929

b. 21,000

 

e)

Aggregated information

- Aggregated volume

- Price

 

 

 

 

As above

f)

Date of the transaction

25 March 2025 and 26 March 2025

g)

Place of the transaction

London Stock Exchange - AIM market

 

 

-ENDS-

 

About Pantheon Resources

Pantheon Resources plc is an AIM listed Oil & Gas company focused on developing its 100% owned Ahpun and Kodiak fields located on State of Alaska land on the North Slope, onshore USA. Independently certified best estimate contingent recoverable resources attributable to these projects currently total c. 1.6 billion barrels of ANS crude and 6.6 Tcf of associated natural gas. The Company owns 100% working interest in c. 259,000 acres.

Pantheon's stated objective is to demonstrate sustainable market recognition of a value of $5-$10/bbl of recoverable resources by end 2028. This is based on bringing the Ahpun field forward to FID and producing into the TAPS main oil line (ANS crude) by the end of 2028. The Gas Sales Precedent Agreement signed with AGDC provides the potential for Pantheon's natural gas to be produced into the proposed 807mile pipeline from the North Slope to Southcentral Alaska during 2029. Once the Company achieves financial self-sufficiency, it will apply the resultant cashflows to support the FID on the Kodiak field planned, subject to regulatory approvals, targeted by the end of 2028 or early 2029.

A major differentiator to other ANS projects is the close proximity to existing roads and pipelines which offers a significant competitive advantage to Pantheon, allowing for shorter development timeframes, materially lower infrastructure costs and the ability to support the development with a significantly lower pre-cashflow funding requirement than is typical in Alaska. Furthermore, the low CO2 content of the associated gas allows export into the planned natural gas pipeline from the North Slope to Southcentral Alaska without significant pre-treatment.

The Company's project portfolio has been endorsed by world renowned experts. Netherland, Sewell & Associates estimate a 2C contingent recoverable resource in the Kodiak project that total 1,208 mmbbl of ANS crude and 5,396 bcf of natural gas. Cawley Gillespie & Associates estimate 2C contingent recoverable resources for Ahpun's western topset horizons at 282 mmbbl of ANS crude and 803 bcf of natural gas. Lee Keeling & Associates estimated possible reserves and 2C contingent recoverable resources totalling 79 mmbbl of ANS crude and 424 bcf natural gas. 

 

 

Further information:

 

UK Corporate and Investor Relations Contact Pantheon Resources plc

Justin Hondris contact@pantheonresources.com

 

Nominated Adviser and BrokerCanaccord Genuity LimitedHenry Fitzgerald-O'Connor, James Asensio, Charlie Hammond+44 20 7523 8000

 

Public Relations Contact BlytheRayTim Blythe, Megan Ray, Matthew Bowld+44 20 7138 3204

 

USA Investor Relations ContactMZ Group

Lucas Zimmerman, Ian Scargill+1 949 259 4987 PTHRF@mzgroup.us

IMPORTANT INFORMATION

This Announcement is released by Pantheon Resources plc and contains inside information for the purposes of Article 7 of UK MAR. It is disclosed in accordance with the Group's obligations under Article 17 of UK MAR.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this Announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKDLBLEXLEBBQ
Date   Source Headline
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update
16th Mar 20232:08 pmRNSUpcoming Webinar – Registration Details
13th Mar 20233:33 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
9th Mar 202312:17 pmRNSAppointment of Independent Non-Executive Director
6th Mar 20237:00 amRNSOperational and corporate update
21st Feb 20236:06 pmRNSAnnual General Meeting & Webinar
21st Feb 20237:00 amRNSOperational update, PDMR & Issue of Equity
16th Feb 20237:00 amRNSAlkaid #2 update – well cleanout completed
10th Feb 20237:00 amRNSAlkaid #2 update
24th Jan 20231:49 pmRNSAlkaid #2 webinar and update
23rd Jan 20237:00 amRNSUpcoming Webinar - Registration Details
13th Jan 202311:03 amRNSConfirmation of Upcoming Webinar
3rd Jan 20237:00 amRNSInvestor Q&A
30th Dec 20227:00 amRNSOperational update
30th Dec 20227:00 amRNSFinal Results for the Year Ended 30 June 2022
14th Dec 20225:00 pmRNSQuarterly Repayment of Unsecured Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.